Clinical-Microbiomics A/S — Credit Rating and Financial Key Figures
Credit rating
Company information
About Clinical-Microbiomics A/S
Clinical-Microbiomics A/S (CVR number: 37230634) is a company from KØBENHAVN. The company recorded a gross profit of 1779 kEUR in 2023. The operating profit was -1981 kEUR, while net earnings were -1951 kEUR. The profitability of the company measured by Return on Assets (ROA) was -3.6 %, which can be considered poor and Return on Equity (ROE) was -3.8 %, which can be considered poor. The equity ratio, a key indicator for solidity, stood at 95.6 %, a level that can be considered to be very good, which means that the majority of assets are financed by equity. Clinical-Microbiomics A/S's liquidity measured by quick ratio was 1.6 which is at a very high level. Thus, the company demonstrates exceptional financial stability, possessing a significant surplus of liquid assets over its short-term liabilities.
Financial information
See financialsGross profit (kEUR)
EBIT (kEUR)
Profitability
Solidity
Key figures (kEUR)
See financials2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Volume | |||||
Net sales | |||||
Gross profit | 13 182.68 | 18 368.35 | 16 768.94 | 2 550.00 | 1 779.00 |
EBIT | 982.76 | 1 442.03 | -1 367.95 | - 750.00 | -1 981.00 |
Net earnings | 106.98 | 669.29 | -1 722.97 | - 927.00 | -1 951.00 |
Shareholders equity total | -4 146.58 | -3 444.96 | 2 825.61 | 16 048.00 | 86 290.00 |
Balance sheet total (assets) | 11 538.52 | 17 596.36 | 28 266.08 | 19 013.00 | 90 236.00 |
Net debt | 2 136.27 | - 268.95 | -4 062.51 | -3 752.00 | - 456.00 |
Profitability | |||||
EBIT-% | |||||
ROA | 7.5 % | 8.3 % | -5.5 % | -3.1 % | -3.6 % |
ROE | 1.2 % | 4.6 % | -16.9 % | -9.8 % | -3.8 % |
ROI | 16.6 % | 16.4 % | -10.4 % | -4.7 % | -3.8 % |
Economic value added (EVA) | 818.35 | 1 179.13 | - 651.00 | - 372.29 | -1 858.99 |
Solvency | |||||
Equity ratio | -26.4 % | -16.4 % | 10.0 % | 84.4 % | 95.6 % |
Gearing | -137.5 % | -206.9 % | 232.1 % | 8.4 % | 1.1 % |
Relative net indebtedness % | |||||
Liquidity | |||||
Quick ratio | 1.0 | 1.2 | 1.1 | 3.6 | 1.6 |
Current ratio | 1.0 | 1.2 | 1.1 | 3.6 | 1.7 |
Cash and cash equivalents | 3 564.48 | 7 397.52 | 10 620.52 | 5 097.00 | 1 410.00 |
Capital use efficiency | |||||
Trade debtors turnover (days) | |||||
Net working capital % | |||||
Credit risk | |||||
Credit rating | BB | BBB | BBB | A | A |
Variable visualization
Roles
Companies in the same industry
Create your own estimates for any company
Valuation analysis
See instructions

... and more!
No registration needed.